Literature DB >> 12668281

Prognostic factors associated with the clinical outcome of cervical intraepithelial neoplasia: a cohort study in Japan.

Masatoshi Yokoyama1, Tsuyoshi Iwasaka, Chisato Nagata, Shiro Nozawa, Soei Sekiya, Yasuo Hirai, Koji Kanazawa, Shinji Sato, Hiroshi Hoshiai, Motoyasu Sugase, Takashi Kawana, Hiroyuki Yoshikawa.   

Abstract

One hundred and eighty-five Japanese women with cervical intraepithelial neoplasia (CIN) were enrolled in this follow-up study. On the basis of the prevalence of human papillomavirus (HPV) DNA in Japanese cervical cancer patients, HPV types were categorized into three groups as follows: (1) high risk (types 16, 18, 33, 52, and 58), (2) intermediate risk (types 31, 35, 39, 51, 56, 59, 68, and 70), (3) low risk (type 6, 30, 42, 53, 54, 55, 66 and unclassified types). High-risk HPV infection was a risk factor for progression of the disease. The regression rate in the HPV negative group was higher (83.3%) than those in the HPV positive groups, but the differences in regression were no longer significant after adjustment for age and CIN grade. It is also noted that a lower cytomegalovirus IgG level and a smaller number of past pregnancies might be associated with the regression of CIN lesions.

Entities:  

Mesh:

Year:  2003        PMID: 12668281     DOI: 10.1016/s0304-3835(02)00715-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

1.  Genotyping of human papillomaviruses by a novel one-step typing method with multiplex PCR and clinical applications.

Authors:  Morie Nishiwaki; Tomohiro Yamamoto; Somako Tone; Taichi Murai; Tatsuya Ohkawara; Takakuni Matsunami; Motoiki Koizumi; Yoshitake Takagi; Jun Yamaguchi; Nobuo Kondo; Jun Nishihira; Takeharu Horikawa; Takashi Yoshiki
Journal:  J Clin Microbiol       Date:  2008-01-30       Impact factor: 5.948

2.  The Neutrophil-Lymphocyte Ratio Predicts Recurrence of Cervical Intraepithelial Neoplasia.

Authors:  Sungwook Chun; Kyusik Shin; Ki Hyung Kim; Heung Yeol Kim; Wankyu Eo; Ji Young Lee; Jeong Namkung; Sang Hoon Kwon; Suk Bong Koh; Hong-Bae Kim
Journal:  J Cancer       Date:  2017-07-15       Impact factor: 4.207

3.  Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study.

Authors:  Changfa Xia; Xiaoqian Xu; Xuelian Zhao; Shangying Hu; Youlin Qiao; Yong Zhang; Raymond Hutubessy; Partha Basu; Nathalie Broutet; Mark Jit; Fanghui Zhao
Journal:  BMC Med       Date:  2021-03-03       Impact factor: 8.775

4.  The predicted effect of changes in cervical screening practice in the UK: results from a modelling study.

Authors:  K Canfell; R Barnabas; J Patnick; V Beral
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640

Review 5.  Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis.

Authors:  Karoliina Tainio; Antonios Athanasiou; Kari A O Tikkinen; Riikka Aaltonen; Jovita Cárdenas; Sivan Glazer-Livson; Maija Jakobsson; Kirsi Joronen; Mari Kiviharju; Karolina Louvanto; Sanna Oksjoki; Riikka Tähtinen; Seppo Virtanen; Pekka Nieminen; Maria Kyrgiou; Ilkka Kalliala
Journal:  BMJ       Date:  2018-02-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.